New Ag Products

Funding Boost

Updated 5/22/2012

MIDDLETON, Wis., – Zurex Pharma, Inc. (Zurex), a life sciences company with a novel antimicrobial technology platform, announced today it has raised $6.2 million in Series A financing, led by Baird Venture Partners and the State of Wisconsin Investment Board ...

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with healthcare acquired infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).